Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


Syneron Medical Appoints Hugo Goldman as Chief Financial Officer

YOKNEAM, Israel, Nov. 5, 2012 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), www.syneron.com, the leading global aesthetic device company, announced today that Hugo Goldman has been appointed Chief Financial Officer, effective immediately. Mr. Goldman replaces David Schlachet, who had been serving as interim Chief Financial Officer since August 2012.

(Logo: http://photos.prnewswire.com/prnh/20120528/535447  )

Prior to joining Syneron, Mr. Goldman served as Chief Financial Officer of Retalix, Ltd., a leading global provider of software and services to high volume, high complexity retailers, that is dual-listed on the NASDAQ and Tel Aviv Stock Exchanges. During his tenure at Retalix, Mr. Goldman played a key role in helping Retalix to grow and improve profitability while developing and successfully executing a growth strategy for the future.  He was instrumental in enhancing its global financial strengths and operating efficiencies and has extensive experience with the finance and investment communities. 

From 2000 to 2007, Mr. Goldman was Chief Financial Officer at AxisMobile (listed on the AIM stock exchange in London), VocalTec Communications Ltd. (listed on the NASDAQ stock exchange) and Algorithmic Research Ltd. (subsidiary of NASDAQ listed company). From 1983 to 1999, he held several finance positions of increasing responsibility in Israel and the United States at Motorola Semiconductor (now Freescale Semiconductor Inc.), ultimately reaching the position Chief Financial Officer of the Company's Israeli operations. Mr. Goldman began his career at the accounting firm Kesselman & Kesselman (now PricewaterhouseCoopers).

Mr. Goldman holds a bachelor's degree in Accounting and Economics from the University of Tel-Aviv and an Executive MBA from Bradford University with distinction. He is a certified public accountant in Israel.

Louis P. Scafuri, Chief Executive Officer of Syneron, said, "We are pleased to welcome Hugo Goldman to the Syneron team. He has served as Chief Financial Officer of several global publicly traded companies, which has given him extensive experience in the areas of finance, business development, compliance, financial reporting and investor relations. He has also had responsibilities with information technology, logistics, human resources and legal departments, giving him a broad array of operational expertise. We believe he is ideally suited to help achieve our goal to continue driving growth while also improving our operating leverage and profitability profile."

Michael Anghel, member of Syneron's Board of Directors and Chairman of the Company's Audit Committee, commented, "Hugo Goldman has a strong professional background with a track record of working closely with senior management and board members to design and implement successful operational strategies. He also has deep experience in financial reporting and compliance, which should allow for a smooth transition as he joins the Company."

About Syneron Medical Ltd.

Syneron Medical Ltd. – a company devoted to real technology, real science and real results – is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint.  The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite.  The Company sells its products under two distinct brands, Syneron and Candela.  The Company's aspiration and commitment to innovation expands Syneron's offering beyond medical device into the largest in-demand applications in beauty - skin lightening.  Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US.  The company markets and services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.  Additional information can be found at www.syneron.com.

SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS

Any statements contained in this document regarding future expectations, beliefs, goals, plans or prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Further, any statements that are not statements of historical fact (including statements containing "believes," "anticipates," "plans," "expects," "may," "will," "would," "intends," "estimates" and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including the risk that the company will not meet stated goals, as well as the risks set forth in Syneron Medical Ltd.'s most recent Annual Report on Form 20-F, and the other factors described in the filings that Syneron Medical Ltd. makes with the SEC from time to time. If one or more of these factors materialize, or if any underlying assumptions prove incorrect, Syneron Medical Ltd.'s actual results, performance or achievements may vary materially from any future results, performance or achievements expressed or implied by these forward-looking statements.

In addition, the statements in this document reflect the expectations and beliefs of Syneron Medical Ltd. as of the date of this document. Syneron Medical Ltd. anticipates that subsequent events and developments will cause its expectations and beliefs to change. However, while Syneron Medical Ltd. may elect to update these forward-looking statements publicly in the future, it specifically disclaims any obligation to do so. The forward-looking statements of Syneron Medical Ltd. do not reflect the potential impact of any future dispositions or strategic transactions that may be undertaken. These forward-looking statements should not be relied upon as representing Syneron Medical Ltd.'s views as of any date after the date of this document.

Contacts:

Hugo Goldman, Chief Financial Officer
Email: hugo.goldman@syneron.com

Zack Kubow, The Ruth Group
646-536-7020
Email: zkubow@theruthgroup.com

SOURCE Syneron Medical Ltd.

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Web 2.0 Latest News
DevOps Summit at Cloud Expo 2014 Silicon Valley was a terrific event for us. The Qubell booth was crowded on all three days. We ran demos every 30 minutes with folks lining up to get a seat and usually standing around. It was great to meet and talk to over 500 people! My keynote was we...

#IoT #IDM #SDAS #infosec

As the Internet of Things continues to expand (and it is expanding rapidly) the issue of access to applications is going to get a lot more messy.

One of the benefits of cloud, so I'm told, is it is "easy access" for everyone...

#DevOps

App deployment should be viewed as a comprehensive, end to end process.But we treat it today like each silo is a fork in a project that never merges back together, causing disjointed operations, reporting, measurement and ultimately, failure to meet business priori...

Cryptocurrencies have gained traction in the past half-decade for a variety of reasons. Bitcoin has become the most popular cryptocurrency in the world due to its sudden rise in value and acceptance within the international marketplace. You might be wondering: What does cloud computing...
HP charts a better path to simplified, just-in-time, and pan-IT support improvements -- despite dynamic and complex IT environments. Much of the attention to coping with mega IT challenges such as cloud, bring your own device (BYOD), mobile applications, and big data focuses on adopti...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE